Frequently Asked Questions
The Biologics Contract Development and Manufacturing Organization (CDMO) Market size will be worth USD 34,378.10 million by 2031 during the forecast period.
The Biologics Contract Development and Manufacturing Organization (CDMO) Market growth rate is 11.0% during the forecast period.
The Increasing Demand for Biologics and Cost-Efficiency and Flexibility are the growth drivers of the Biologics Contract Development and Manufacturing Organization (CDMO) Market.
The surgery, product, and end-user are the factors on which the Biologics Contract Development and Manufacturing Organization (CDMO) Market research is based.
The major companies in the Biologics Contract Development and Manufacturing Organization (CDMO) Market are Boehringer Ingelheim Group (Germany), Wuxi Biologics (China), Samsung Biologics (South Korea), Lonza Group (Switzerland), Fujifilm Diosynth Biotechnologies USA Inc. (U.S.), Toyobo Co. Limited (Japan), Parexel International Corporation (U.S.), Icon PLC (Ireland), Binex Co. Limited (South Korea), JRS Pharma (Germany), Rentschler Biotechnologies (Germany), AGC Biologics (U.S.), Catalent Inc. (U.S.).
